Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Alpine Immune Sciences (ALPN) Earnings Date, Estimates & Call Transcripts

Alpine Immune Sciences logo
Get Alpine Immune Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpine Immune Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALPN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALPN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Alpine Immune Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244-$0.45-$0.38-$0.42
Q2 20244-$0.46-$0.41-$0.44
Q3 20244-$0.50-$0.44-$0.47
Q4 20244-$0.53-$0.47-$0.49
FY 202416-$1.94-$1.70-$1.81
Q1 20251-$0.52-$0.52-$0.52
Q2 20251-$0.53-$0.53-$0.53
Q3 20251-$0.51-$0.51-$0.51
Q4 20251-$0.52-$0.52-$0.52
FY 20254($2.08)($2.08)($2.08)

Alpine Immune Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
5/9/2024Q1 2024-$0.43-$0.28+$0.15-$0.28$5.50M$7.03M
3/18/2024Q4 2023-$0.32$0.15+$0.47$0.15$6.90M$30.85M
11/14/2023Q3 2023-$0.35-$0.24+$0.11-$0.24$8.73M$10.04M
8/14/2023Q2 2023-$0.38-$0.27+$0.11-$0.27$8.08M$8.59M
5/11/2023Q1 2023-$0.37-$0.28+$0.09-$0.28$8.60M$9.39M
3/23/2023Q4 2022-$0.27-$0.41 -$0.14-$0.41$10.42M$2.78M    

Alpine Immune Sciences Earnings - Frequently Asked Questions

Alpine Immune Sciences (NASDAQ:ALPN) has a recorded annual revenue of $56.52 million.

Alpine Immune Sciences (NASDAQ:ALPN) has a recorded net income of -$32.18 million. ALPN has generated -$0.64 earnings per share over the last four quarters.

Alpine Immune Sciences's earnings are expected to decrease from ($1.74) per share to ($1.90) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:ALPN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners